Vaxcyte Inc (PCVX) Stock Price, Quote, News & History

PCVXNASDAQ
$58.07
-0.79-1.34%
At close: Aug 14, 5:00 PM EST
$58.07
N/A
After Hours: Aug 14, 4:43 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-881.23M
Investing Cash Flow (TTM)
150.60M
Financing Cash Flow (TTM)
606.02M
Free Cash Flow (TTM)
-921.07M
Capital Expenditure (TTM)
-39.84M
Net Change in Cash (TTM)
-124.61M

Analyst Trends and Forecast

1
Feb
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$7.27B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
3.18
Earnings Yield % (TTM)
-12.96%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$18.53

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$183.19M
Debt to Equity
0.04
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$58.11
Close
$58.07
Volume / Avg.
656.56K / 1.44M
Day Range
$57.30 - $58.75
52 Wk Range
29.87 - 65.00
Market Cap
$8.64B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
55
Short Interest
9.77%
Days to Cover
14.82

About

Sector
Health Care
Industry
Biotechnology
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel c...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Vaxcyte (PCVX) stock?

A

You can purchase shares of Vaxcyte (NASDAQ:PCVX) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Vaxcyte (PCVX) stock?

A

Vaxcyte has a consensus price target of $121.00.

Q

What is the current price for Vaxcyte (PCVX)?

A

The stock price for Vaxcyte (NASDAQ: PCVX) is $58.07 last updated August 14, 2026 at 4:43 PM EDT.

Q

Does Vaxcyte (PCVX) pay a dividend?

A

There are no upcoming dividends for Vaxcyte.

Q

When is Vaxcyte (NASDAQ:PCVX) reporting earnings?

A

Vaxcyte does not have any upcoming earnings scheduled.

Q

Is Vaxcyte (PCVX) going to split?

A

There is no upcoming split for Vaxcyte.

Q

What sector and industry does Vaxcyte (PCVX) operate in?

A

Vaxcyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.